# SciFounders

> SciFounders is a VC fund backing Health Care and Biotechnology. See 14 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Francisco, United States
- Total investments: 14
- Last investment: Jan 2026
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/scifounders/
- X (Twitter): https://twitter.com/SciFounders/
- Website: https://scifounders.com/

SciFounders is a VC fund in San Francisco focused on Health Care and Biotechnology. Helping science companies get started. We invest in technical startups from idea stage to Series A. We start companies too.

## Contacts

5 contacts available for SciFounders. Shizune tracks 3 team members at SciFounders. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/scifounders?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3.2M–$5M |
| Pre-Seed | $400k–$400k |
| Series A | $2.5M–$21M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 43% |
| Biotechnology | 5 | 36% |
| Medical | 4 | 29% |
| Therapeutics | 3 | 21% |
| Medical Device | 3 | 21% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 36% |
| Pre-Seed | 5 | 36% |
| Series A | 1 | 7% |
| Funding Round | 1 | 7% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 6 | 43% |
| Ireland | 1 | 7% |
| United Kingdom | 1 | 7% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alexander Schubert | Co-Founder and Partner | 0 | https://shizune.co/investors/profile/alexander-schubertl |
| Lucas Harrington | Co-founder | 0 | https://shizune.co/investors/profile/lucas-harrington-766c |
| Matthew Krisiloff | Partner and Co-Founder | 1 | https://shizune.co/investors/profile/matthew-krisiloff |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Luminate | Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. | $21M | Series A | Jan 07, 2026 |  |
| Olio Labs | Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. |  |  | Mar 19, 2025 |  |
| Olio Labs | Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. | $4.5M | Seed | Mar 19, 2025 |  |
| Luminate | Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. | $2.5M | Series A | Dec 04, 2024 |  |
| Current Surgical | Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors. The company was founded in 2020 and has its headquarters in Washington, DC. | $3.2M | Seed | Feb 21, 2023 |  |
| Current Surgical | Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors. The company was founded in 2020 and has its headquarters in Washington, DC. |  | Seed | Feb 21, 2023 |  |
| Luminate | Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. | $5M | Seed | May 30, 2022 |  |
| Engage Bio | mRNA immunotherapies to defeat cancer | $3.9M | Seed | May 01, 2022 |  |
| ImmTune Therapies | ImmTune Therapies is an operator of a cell therapy process intended to cut out complicated biomanufacturing processes. The company's platform brings cell therapies to many, enabling patients to enjoy a reduction in the costs of treatment, which were previously a burden on patients. |  | Seed | May 01, 2022 |  |
| Inherent Targeting | Inherent Targeting develops fluorescent contrast agents that target nerves to improve surgical outcomes. The company was founded in 2019 and is headquartered in Portland, Oregon. |  | Pre-Seed | Dec 01, 2021 |  |

10 of 14 investments shown.

## Co-investors
- [Faber](https://shizune.co/investors/profile/faber-ventures) — VC Fund, 5 deals together
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 4 deals together
- [Elkstone Capital Partners](https://shizune.co/investors/profile/elkstone-capital-partners) — VC Fund, 3 deals together
- [Pioneer Fund](https://shizune.co/investors/profile/pioneer-fund) — VC Fund, 3 deals together
- [1517 Fund](https://shizune.co/investors/profile/1517-fund) — VC Fund, 2 deals together
- [Atlantic Bridge](https://shizune.co/investors/profile/atlantic-bridge) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund
- [NDRC](https://shizune.co/investors/profile/ndrc) — VC Fund
- [Act Venture Capital](https://shizune.co/investors/profile/act-venture-capital) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Ireland](https://shizune.co/investors/medical-device-investors-ireland)
- [Medical VC Funds in Ireland](https://shizune.co/investors/medical-vc-funds-ireland)
- [Medical Device VC Funds in Ireland](https://shizune.co/investors/medical-device-vc-funds-ireland)
- [Health Care VC Funds in Ireland](https://shizune.co/investors/health-care-vc-funds-ireland)
- [Health Care Investors in Ireland](https://shizune.co/investors/health-care-investors-ireland)
- [Biotechnology VC Funds in Ireland](https://shizune.co/investors/biotechnology-vc-funds-ireland)

## FAQ

### What does SciFounders invest in?

SciFounders invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Pre-Seed stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is SciFounders's check size?

SciFounders typically joins rounds of $3.2M–$5M at Seed, $400k–$400k at Pre-Seed and $2.5M–$21M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SciFounders participates in.

### How do I contact SciFounders?

Public channels for SciFounders include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SciFounders?

The team at SciFounders includes Alexander Schubert (Co-Founder and Partner), Lucas Harrington (Co-founder) and Matthew Krisiloff (Partner and Co-Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co